Prof.Dr. Lauro Domingos Moretto
President Emeritus of the Brazilian Academy of Pharmaceutical Sciences.Professor and holds a degree in Pharmacy and Biochemistry, a Master’s degree in Pharmaceutical-Biochemical Technology, and a Doctorate in Food Sciences.
A Pharmacy and Biochemistry graduate from the University of São Paulo (USP) in 1963, he also holds a Master’s degree in Pharmaceutical-Biochemical Technology and a Doctorate in Food Sciences from the same institution.
He served as a professor at the School of Pharmaceutical Sciences at USP from 1964 to 2008. He held technical and executive positions at major pharmaceutical companies, including Johnson & Johnson, Instituto De Angeli, and Boehringer Ingelheim, and subsequently served as Executive Vice President of Sindusfarma, the Pharmaceutical Products Industry Association of the State of São Paulo.
In 2019, he was awarded the title of Honorary Citizen of São Paulo by the São Paulo City Council. In July 2025, he was inducted as a Corresponding Member of the National Academy of Pharmacy of Peru.
back to CO-AUTHORS
About Prof.Dr. Lauro Domingos Moretto
Prof. Dr. Lauro D. Moretto is President Emeritus of the Brazilian Academy of Pharmaceutical Sciences.
A pharmaceutical biochemist who graduated in 1963 from the School of Pharmaceutical Sciences at the University of São Paulo (USP). He served as a faculty member at the same institution from 1964 to 2008, teaching Quantitative Analytical Chemistry, Pharmaceutical Chemical Technology, and Production Supervision. He holds a Master’s degree in Pharmaceutical Chemical Technology and a Doctorate in Food Sciences, both from the School of Pharmaceutical Sciences at the University of São Paulo. He teaches postgraduate courses and delivers lectures at universities in Brazil and abroad.
From 1961 to 1992, he held technical and executive positions at the pharmaceutical companies Johnson & Johnson do Brasil, Instituto De Angeli do Brasil, and Boehringer Ingelheim Brasil. Since 1992, he has served as Executive Vice President of Sindusfarma, the Pharmaceutical Products Industry Association of the State of São Paulo.
He is the author of Production Management for Pharmacists (Gerenciamento da Produção para Farmacêuticos), co-author of 45 technical, regulatory, and occupational safety books published as part of Sindusfarma’s collections, and coordinator of five institutional books published by the organization. He has also authored scientific papers and articles for professional and general audiences on management and health regulation topics.
Prof. Dr. Moretto has served as a member of CTNBio (the National Technical Commission on Biosafety) under the Ministry of Science and Technology; as a member of the National Health Council (CNS) under the Ministry of Health; and as a member of CONCEA (the National Council for the Control of Animal Experimentation) under the Ministry of Science and Technology. He also served on the Permanent Commission of the Brazilian Pharmacopoeia at the Secretariat of Health Surveillance of the Ministry of Health. He currently serves on the Deliberative Council of the Brazilian Pharmacopoeia at ANVISA (the Brazilian Health Regulatory Agency), under the Ministry of Health.
His distinctions include the Certificate of Honorable Mention from the Regional Council of Pharmacy of the State of São Paulo, the title of Emeritus Member of the Federal Council of Pharmacy, and the Cândido Fontoura Medal of Pharmaceutical Industrial Merit, awarded by Sindusfarma. He has been a Full Member of the National Academy of Pharmacy since 2004. He was elected President of the Academy for the 2011–2013 term and re-elected for the 2013–2015 term.
Chapter Theme
VACCINES FOR OLDER ADULTS: IMPACT ON LONGEVITY AND QUALITY OF LIFE
Co-authored with Dr. Lauro Domingos Moretto, Dr. Nelson de Franco Jr., and Prof. Dr. Marco Antonio Stephano.
In this chapter, Prof. Dr. Marco Antonio Stephano, together with his co-authors Dr. Lauro Domingos Moretto and Dr. Nelson de Franco Jr., presents a science-based reflection on the role of vaccination as one of the pillars of healthy aging. In a context marked by increasing life expectancy and the challenges posed by immunosenescence—the natural decline of the immune system associated with aging—the authors demonstrate that prevention through vaccination goes far beyond protection against infectious diseases.
Drawing on up-to-date scientific evidence, the chapter reveals how immunization contributes to preserving autonomy, functional capacity, and quality of life among older adults by reducing hospitalizations, severe complications, and the losses associated with frailty. More than simply adding years to life, vaccination is presented as a strategy to ensure independence, dignity, and well-being throughout the aging process.
By integrating public health, scientific innovation, and preventive care, this chapter invites readers to understand that a happy and fulfilling longevity is also built through conscious choices that protect life and make it possible to live longer—and better.